ANNEXON
Pharmaceutical preparations for the treatment of Huntington's Disease, amyotrophic lateral sclerosis (ALS), lupus, cold agglutinin disease (CAD), chronic inflammatory demyelinating polyneuropathy (CIDP), and myasthenia gravis (MG)
Abandoned · August 12, 2024 · 98694164 ·